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Abstract (217/220 word limit) 1 
Introduction 2 
Delusional infestation is a well-recognised delusional disorder presenting as the persisting belief of 3 
the presence of parasitic or other infestations. Combined clinics have been run by dermatology and 4 
psychiatry in a small number of centres. Here we report the first few years of a unique combined 5 
clinic run with experts in infectious diseases/tropical medicine and psychiatric management of 6 
delusional infestation. 7 
Methods 8 
Review of all patients seen at the combined assessment clinics run at LSTM between 19 December 9 
2011 and 31 October 2016. Data were collected prospectively as part of clinical assessment. 10 
Descriptive analysis of these data was performed to examine clinical features at assessment, 11 
investigations performed and treatment outcomes. 12 
Results 13 
Seventy-five patients were assessed. 52 (69%) were given the formal diagnosis of delusional 14 
infestation. 64% of individuals gave a history of travel but no significant tropical or infectious 15 
diagnosis was made.  61% of those who returned for follow-up reported improvement in symptoms. 16 
The CGI-S improvement was 1.36 for the DI patients, but only 0.63 for non-DI patients. DI patients 17 
were more impaired at baseline (5.0 vs 4.1). Health anxiety was the commonest diagnosis seen in 18 
those not considered to have DI. 19 
Conclusion 20 
Combined clinics to treat DI are effective in improving patient outcome. A significant minority of 21 
patients referred do not have a diagnosis of DI.  22 
 23 
Keywords: Combined clinics, Delusional infestation, infectious diseases, tropical medicine, psychiatry 24 
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Introduction 1 
Delusional infestation (DI, previously known as delusional parasitosis or Ekbom’s syndrome) usually 2 
causes considerable difficultly for patients and has been recognised by clinicians for over 100 years 3 
(1-3). The condition presents as a fixed belief that the patient’s skin, body or environment is infested 4 
by living or inanimate pathogens with no medical evidence for this.  Primary cases of DI meet the 5 
criteria for persistent delusional disorder within ICD-10 (F22.0).  Secondary cases related to 6 
substance misuse, prescribed drugs (such as dopaminergic agents) and medical and psychiatric 7 
diagnosis are also well recognised (3).  Research into the underlying mechanism for DI suggest 8 
dysfunction within the regions of the brain responsible for judgement, sensation and learning, 9 
supporting the hypothesis that these delusional beliefs are due to misinterpretations of peripheral 10 
signals that result in favouring of an unlikely explanation of these sensations (errors of probabilistic 11 
reasoning) (4).  Antipsychotic medication has been shown to improve symptoms in DI (5-7), 12 
however, engaging patients can be challenging, resulting in high rates of non-adherence to 13 
recommended medication (8, 9). Combined clinical services with dermatology or other medical 14 
services have been proposed as the optimal way to manage patients with DI, allowing them to 15 
engage with psychiatric services (10). There is increasing evidence that this approach is likely to be 16 
cost effective in reducing the overall number of investigations and repeat referrals which can occur 17 
in DI (11).   18 
Much less common is a combined clinical service run in conjunction with infectious disease or 19 
tropical medicine specialists. Currently, we are only aware of such clinics in Liverpool and Berlin. 20 
However, the Berlin clinic only has access to psychiatric expertise, rather than being a truly jointly 21 
run clinic. UK residents are travelling abroad more frequently (12) with increased exposure risks for 22 
unusual infections and infestations. Travel has previously been described as a possible trigger for DI 23 
(13, 14), as well as reports of cultural variation in the presentation of DI in different parts of the 24 
globe (15-18).  There have also been reports of DI where an individual could have been exposed to 25 
parasitic infection such as entomologists (Stanhope, Carver et al. 2015) or animal owners presenting 26 
to vets with alleged symptoms of infestation in their pets. (19-21).  This paper discusses the 27 
experience of a combined psychiatry and tropical medicine clinic for DI, prevalence of illnesses in the 28 
patients assessed, outcomes, the approach used in the clinic, and a review of clinical database of 29 
cases. 30 
Methods 31 
A combined psychiatry and tropical medicine clinic has been running twice per month since 2011 at 32 
the Liverpool School of Tropical Medicine, UK. Referrals are accepted from within the Merseyside 33 
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and North Wales regions as well of out of area referrals. Referrals were accepted from primary and 1 
secondary care and were screened by consultants from both disciplines for suitability (Figure 1). The 2 
aim of this screening process is to identify those patients felt most likely to have DI rather than 3 
requiring assessment at the general tropical medicine clinic. Criteria identified in referral letters 4 
which led to prioritisation for assessment in the DI clinic include a history suggestive of DI (a 5 
persistent, strong belief of being infested in combination with unusual constellations of symptoms), 6 
a previous diagnosis of DI made by a colleague, and the duration and degree of distress associated 7 
with the symptoms. .  Prior to attending the clinic, patients are asked to have basic routine blood 8 
tests (full blood count, urea and electrolytes, liver function test) and an ECG. This is to help with the 9 
exclusion of real infestations (high eosinophil count) and provides a baseline QTc interval in case 10 
antipsychotics are suggested.  Each clinic session is booked for 1 hour, and an introduction of all 11 
team members and the aims of the clinic is performed at the beginning of each clinic. The 12 
psychiatrist is introduced as an integral part of the clinic, as symptoms such as those experienced by 13 
the patient often cause significant distress and can be associated with psychiatric morbidity. The 14 
initial clinic appointment is led by the Tropical Medicine Consultant taking a classical medical history 15 
and examination. Important parts of the history include any travel history or other activities which 16 
could expose an individual to unusual infections or infestations.  Examination includes a close 17 
examination of areas of concern for the patient, perceived areas of skin change or infestation.  18 
Investigations are limited only to those, which the tropical medicine consultant feels are appropriate 19 
given the history and examination. Any specimens brought by the patient are reviewed in the 20 
diagnostic parasitology laboratory. It is pointed out that this is a specialist laboratory able to identify 21 
most known parasites by microscopy. Patients are encouraged to provide specimens for examination 22 
because it helps with any later explanations of the assessment. Where appropriate, a diagnosis of 23 
primary DI (persistent delusional disorder within ICD-10; F22.0), or of DI in the context of another 24 
illness (secondary DI) (10) is made. In accordance with ICD-10 F22.0, a diagnosis of primary DI is 25 
made in the presence of a persistent stable delusional belief of being infested as the main clinical 26 
feature in the absence of schizophrenic symptoms, marked blunted affect or evidence of organic 27 
brain disease. In the presence of other organic, psychiatric or neurological disorders, a diagnosis of 28 
secondary DI is made.  Alternative diagnoses were made according to standard diagnostic criteria, of 29 
note the diagnosis of ‘Health Anxiety’ was made with reference to ICD-10 F45.2 Hypochondriacal 30 
disorder. 31 
At this stage the Tropical Medicine consultant explains to the patient whether we feel that the 32 
presentation is likely to be due to infestation or not, and the rationale behind this decision. It is 33 
pointed out that the patient’s symptoms are believed and that the clinicians’ intention is to identify 34 
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the cause of those symptoms with an open mind. If DI is felt to be a likely diagnosis, the clinicians 1 
explain three possible options with the aim of introducing the possibility of a non-parasitic 2 
explanation of the symptoms to the patient. The three explanations include a hitherto unknown 3 
infestation, an infestation which has subsided but left the patient with residual symptoms, or an 4 
illness of the brain.  If the feeling of the team is that this is likely to be DI then the Psychiatrist 5 
present may take over leading the consultation at this stage.  We offer the explanation that 6 
sensations can be abnormally interpreted by the brain; and the benefit of anti-psychotic medication 7 
in ameliorating these are emphasised.  We do not explicitly explain the diagnosis as a delusional 8 
illness at an early stage unless the patient specifically asks. Follow-up sessions are structured along 9 
similar lines with Tropical Medicine consultant’s emphasising the lack of physical evidence of 10 
infestation and risk factors whereas the psychiatrist emphases the problems with errors of 11 
probabilistic reasoning, encouraging adherence to medication.  12 
Patients often respond with a high degree of scepticism to any explanation of symptoms that does 13 
not fit their own   (of being infested). However, by building up rapport and trust it is often possible 14 
to persuade patients to try medication against their “better judgment”. In other words, they may try 15 
the medication because they are persuaded by the possibility of an alternative explanation, because 16 
they trust the doctors to have their best interest at heart, or because they feel they have nothing to 17 
lose by trying. Occasionally, they become dismissive and it requires skill to keep them on board, 18 
which is possible in most cases. The degree to which patients are able to consider an alternative 19 
explanation usually corresponds with the degree of their delusional intensity.   20 
A clinical database was collected prospectively focusing on initial assessment, duration and severity 21 
of symptoms, clinical diagnosis made during assessment and follow-up appointments. Additional 22 
information on clinical presentation and previous investigations was collected from clinical notes 23 
and clinic letters retrospectively, and added to the database.  Descriptive statistics were used. The 24 
nature of the clinic meant that formalised statistical analysis was not carried out. Data were 25 
presented according to final clinical diagnosis and categorised as  i) all DI (primary and secondary 26 
combined) and ii) non-DI patients. Outcome data are collected with Clinical Global Impressions Scale 27 
(CGI-S) (22), which are routinely generated for most patients. CGI-S scores are clinician rated, well 28 
validated, have high inter-rated reliability and take a holistic approach to the patient’s overall level 29 
of impairment. A score of 1 means “no illness” whilst the highest score of 7 means “one of the worst 30 
cases seen”.   31 
Results 32 
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Seventy-five patients attended for assessment between 19 December 2011 and 31 October 2016 1 
(Table 1). Approximately two thirds of clinic attendees were diagnosed with DI (n=52/75), two of 2 
whom had a shared delusional belief. This shows a reasonably successful screening process. No 3 
patient objected to the presence of the psychiatrist. Five patients had secondary DI, with illicit drug 4 
use (cannabis, amphetamines and cocaine), schizoaffective disorder, depression, and dopaminergic 5 
Parkinson’s drugs being the causes.  Health anxiety was the commonest diagnosis seen in those not 6 
considered to have DI (n=8/23).  All patients with health anxiety fulfilled general ICD-10 criteria for 7 
F45.2 (hypochondriacal disorder, sometimes known as illness anxiety disorder), but some focussed 8 
their anxieties on overvalued ideas about infestations. Other causes included: Irritable Bowel 9 
Syndrome (2), Depression (2), no illness identified (2), Anxiety (2), Depression and anxiety (1), 10 
Chronic Fatigue Syndrome (1), gut motility disorder (1), impetigo (1), idiopathic pruritus ani (1), 11 
diagnostic uncertainty (2). Psychiatric diagnoses were made using ICD-10 criteria; some patients 12 
came with diagnoses made by external clinicians, which we confirmed. Reported symptoms were 13 
very similar between DI and non-DI patients, abnormal sensation were common in non-DI patients 14 
but almost universally seen in DI (Table 2).  Most patients had been investigated previously and had 15 
often seen multiple specialties as well as attending private clinics and private (unregulated) 16 
laboratories.  Previous treatment for parasitic infestation was common, often initially by GPs and 17 
then procured from alternative sources by patients. Multiple courses of anti-helmenthic or anti-18 
parasitic agents had often been taken.  Symptoms had often been present for many years (up to 20 19 
years in some cases). Patients commonly reported medical co-morbidities but this was seen more 20 
frequently in those not diagnosed with DI.  A previous psychiatric diagnosis was present in around 21 
40% of patients of both groups. 22 
Patients were investigated in accordance with the agreed approach in clinic. Only tests, which the 23 
Tropical Medicine Physician felt were appropriate were done. However, all specimens brought to 24 
clinic were reviewed. The specimen sign at the first clinic appointment was commoner in those with 25 
DI (39%, 20/52 vs 30% 7/23), but when requested to produce a specimen after clinic review this 26 
increased in both groups (58% 30/52 vs 48% 11/23).  The majority of specimens demonstrated 27 
normal epithelial cells, skin debris and vegetable matter. Four samples demonstrated insects 28 
including one head louse, one cat flea, one non-biting midge and a carpet beetle.  Stool microscopy 29 
was performed on approximately 43% of both DI and non-DI patients (22/52 vs 10/23). One patient 30 
had Entomoeba Histolytica/Coli and Blastocystis identified in their stool but it was not felt that this 31 
was the cause of their symptoms (DI secondary to cannabis use, good response to antipsychotics).  32 
Eosinophilia was seen in around 25% of all patients (13/52 vs 6/23).  This was generally low level and 33 
not confirmed on repeat testing.  Serology was performed more commonly in patients with DI (46% 34 
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24/52 vs 26% 6/23), including any relevant non-infectious tests such as autoantibody screen. No 1 
tropical infections or autoimmune conditions were identified through this screening. 2 
Patient outcome was variable. Loss to follow-up and erratic-attendance at follow-up clinic 3 
appointments was common (Table 3).  A few patients requested discharge from clinic as they did not 4 
agree with the diagnosis of DI or the treatment approach. 77% of patients diagnosed with DI were 5 
offered antipsychotics at some time during their clinic attendance, but only 28% of these reported 6 
good adherence to treatment.  Interestingly, patients who reported good or partial adherence to 7 
antipsychotics had a longer average duration of symptoms (67.8 (sd 72) and 82.6 (sd 83) months 8 
respectively) than those with poor adherence (23.8 (sd 18.1) months). 57% of those who returned 9 
for follow-up appointments reported an improvement in their symptoms.   10 
Discussion 11 
Joint or combined clinics between Liaison Psychiatry and either dermatology or tropical medicine 12 
have been proposed as a way forward in the treatment of DI, although few such clinics exist. The 13 
overall success rate in our combined clinic was good with 61% of those who were not lost to follow 14 
up reporting improvement. Unsurprisingly, those with good adherence improved much more 15 
(almost 2 CGI-S scores reduction) than those with poor adherence who showed little improvement. 16 
31% of all patients seen were not diagnosed with DI, which seems acceptable for a clinic that sees 17 
patients with a complex infestation symptom history. Equally, it suggests that the clinicians keep an 18 
open mind with regards to the diagnosis, which is an important aspect of the clinic’s approach. No 19 
infestations were identified, suggesting an excellent screening process with regard to identifying 20 
patients without actual current infestations. 40% of our DI patients had a past psychiatric history, 21 
which is similar to research done at a psycho-dermatology clinic in London where DI patients are 22 
seen (23).  23 
With regards to the alleged pathogens and symptoms we had a high number of alleged worms 24 
compared to previous studies (31% in our sample, compared to 6% in a previous sample) (24). In a 25 
previous study (25) it was the combined clinic in Berlin, also run by a School of Tropical Medicine, 26 
which had most alleged worms in their sample. In comparison, all combined clinics run with 27 
dermatologists had few patients complaining of alleged worms. This indicates there are differences 28 
amongst combined clinics with clinics run by dermatologists where skin complaints rather than 29 
systemic infestations seem to be the main presenting problem, having a different focus of patient 30 
complaints. These differences are confirmed by our finding that our patients almost all complain 31 
about abnormal sensations, whereas few have primary skin complaints.  We also know from further 32 
analysis of our group’s data that despite this difference, the baseline CGI-S scores appear to be very 33 
Page 8 of 12 
 
similar in all specialist clinic settings (26). This shows that the overall impairment of patients because 1 
of the illness is similar in all settings despite a different patient mix. It is unclear at this point whether 2 
specific presentations of DI may be more difficult to treat than others. Anecdotally, we believe that 3 
patients who present with systemic rather than defined skin symptoms may be more difficult to 4 
treat, because it is more difficult to discuss diagnosis them with unspecific terms such as 5 
“unexplained dermopathy”, and it is rarely possible to give them dermatological treatment to 6 
facilitate engagement in the treatment process.  7 
 In our patients, those with a diagnosis of DI were significantly more impaired at baseline with a 8 
whole CGI-S score difference compared to those without a DI diagnosis. Otherwise, the two samples 9 
were remarkably similar. The only other significant difference was the lack of illicit drug use in the 10 
non-DI group compared to the DI group. These findings do not suggest any specific indicators that 11 
can differentiate DI and non-DI patient a priori to aid the screening process. 12 
Recent research has shown that the longer DI remains untreated, the worse the prognosis becomes 13 
(26), increasing pressure to intervene early with DI patients. This increases the need for specialist 14 
settings, as treatment rejection is high in routine primary care or dermatology settings (3). It also 15 
highlights the need for early referral and treatment to optimise outcome. In combined clinics with 16 
dermatology and psychiatry the cost effectiveness of such clinics has already been shown, compared 17 
to standard treatment per year prior to referral to the combined clinic. Altaf et al showed a 42% 18 
reduction in overall treatment costs, indicating that psychodermatology clinics are a cost-effective 19 
service for managing patients with DI (11). We have not formally evaluated the cost-effectiveness of 20 
our clinic but it is likely that any effective combined clinic will reduce costs. 21 
The disadvantage of tertiary settings is that is may be difficult to link in with local psychiatric or 22 
primary care services, or, if the patient does not improve, there may be no back-up system or 23 
associated community service that can take over the engagement of the patient. Long-term 24 
aftercare therefore remains a problem when patients refuse the engage with local services. It begs 25 
the question whether Tropical Medicine/Infectious Diseases services along with Dermatology should 26 
be up-skilled to deal with DI patients more effectively without the need for rare tertiary services to 27 
widen the options for patients and improve referral to treatment times. Given the complexity of 28 
some of the psychiatric aspects of the illness (risk, antipsychotic treatment, possible use of mental 29 
health legislation) close links with local psychiatric services should promote the safety and feasibility 30 
of such an up-skilling process. 31 
 32 
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Conclusion 1 
Combined clinics for DI between Tropical Medicine/Infectious Diseases and Psychiatry services are 2 
effective in delivering improved outcomes. The patients’ symptom focus differs somewhat from 3 
those presenting to Dermatology, presenting additional challenges. Early treatment remains 4 
important. The lack of combined clinics makes the up-skilling of infectious disease/tropical medicine 5 
clinicians in DI desirable.  6 
 7 
  8 
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Figure caption 20 
Figure 1 Flow chart of study screening process and clinical approach. DI = Delusional Infestation. 21 
Table 1 Baseline assessment  
 DI (n=52) Non-DI (n=23) 
Age (Med (IQR)) 56.7 49.7 
Sex (Female, %) 35 (67%) 20 (87%) 
Referral Source (%) 
GP 
ID/Trop Med 
Dermatology 
Psychiatry 
Other  
  
38 (73%) 18 (78%) 
3 (6%) 0 
7 (14%) 2 (9%) 
1 (2%) 0 
3 (6%) 2 (9%) 
Duration of Symptoms (months,sd) 56 (sd 62) 66 (sd 73) 
Previous Investigations (Yes, %) 42 (82%) 20 (87%) 
Tropical travel history (Yes, %) 36 (69%) 12 (57%) 
Any previous treatment for parasitic infestation 
(%) 
46 (89%) 15 (68%) 
Accompanied at clinic (%) 19 (37%) 4 (20%) 
Medical PMH (%) 46 (89%) 22 (96%) 
Psychiatric PMH (%) 21 (40%) 9 (39%) 
Illicit drug use reported (%) 5 (10%) 0 
Drug of Abuse Screen Positive 6 (12%) 3 (13%) 
CGI-S 5.02 (sd 0.71) 4.09 (sd 1.06) 
Visual impairment (%) 10 (19%) 2 (9%) 
Key: sd = standard deviation, PMH = Past Medical History, CGI = Clinical Global Impression Score 
Table 2 Patient Reported Symptoms*  
 DI (n=52) Non-DI (n=23) 
Skin Change 57% (27/47) 55% (12/22) 
Abnormal sensation 98% (49/50) 85% (17/20) 
‘Worms’ in stool 31% (15/49) 38% (8/21) 
Pruritis Ani 37% (10/27) 33% (5/15) 
Poor Sleep 81% (13/16) 100% (6/6) 
*Not all patients had this information recorded. Percentage is for the patients with available 
information 
  
Table
Table 3 Outcome 
 DI (n=52) Non-DI (n=23) 
Median number of follow-up appointments 
(Inter Quartile Range) 
2 (1-3) 2 (1-2) 
Lost to follow-up/ missed follow-up 
appointments 
22/52 (42%) 4/23 (17%) 
Offered antipsychotics at DI Clinic 40/52 (77%) 0/23 
Reported adherence to antipsychotics   
Good 11/40 (28%)  
Partial 8/40 (20%)  
Poor 10/40 (25%)  
Refused Treatment 4/40 (10%)  
Unknown/Lost to follow up 7/40 (17%)  
Reported improvement in symptoms 22/36 (61%) 7/11 (63%) 
CGI-Schange   
Overall -1.36 (sd 1.71) -0.625 (sd 1.2) 
Reported treatment adherence    
Good  -1.75 (sd 1.58)  
Partial -1.63 (sd 1.76)  
Poor -0.29 (sd 1.3)  
Key: sd = standard deviation, CGI-S = Clinical Global Impression Score 
Persistent, strong belief of infestation with a 
constellation of symptoms suggestive of DI
Distress associated with symptoms despite previous 
investigation and assessment
Previous diagnosis of delusional infestation
Referral Screening
Led by Tropical Medicine Consultant, all team members introduced. 
Open mind regarding diagnosis.
Medical/Psychiatric history and examination.
Baseline investigations including FBC, U&E, LFT, ECG and drugs of abuse screen.  Other 
investigations limited to those indicated by Tropical Medicine Consultant.
All specimens of alleged parasites examined at Diagnostic Parasitology Laboratory.
Initial Appointment
Features 
suggestive of DI
General Tropical Disease 
Outpatient Appointment
or
Discussion with referring team 
regarding alternative 
investigation or referral
Features not
suggestive of DI
Results of investigations explained to patient by Tropical Medicine Consultant in 
conjunction with Psychiatry Consultant.
Management options discussed according to diagnosis.  Psychiatry Consultant takes 
lead in discussions regarding DI diagnoses.
Follow up Appointment
Explain possible 
explanations for symptoms 
(see main text)
Offer antipsychotic 
medication
Primary DI
Treat underlying condition or 
stop offending medication
Offer antipsychotic 
medication
Secondary DI
Treat according to illness
Refer to appropriate 
services
Not DI
Reinforcement of diagnosis and treatment adherence.
Subsequent Appointments
Figure Click here to
access/download;Figure;Todd_TRSTMH_Figure1.pptx
